Voloridge Investment Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-69,114	Closed	-$259K	–	1335
2024 Q1	$259K	Buy	+69,114	New	+$405K	﹤0.01%	1093
2023 Q4	–	Sell	-386,690	Closed	-$3.23M	–	1391
2023 Q3	$3.23M	Sell	386,690 -563,774	-59%	-$6.44M	0.02%	788
2023 Q2	$12.6M	Sell	950,464 -764,942	-45%	-$9.3M	0.06%	402
2023 Q1	$19.9M	Buy	1,715,406 +1,523,472	+794%	+$15.1M	0.1%	281
2022 Q4	$1.57M	Buy	+191,934	New	+$1.65M	0.01%	1033
2022 Q3	–	Sell	-220,926	Closed	-$976K	–	1570
2022 Q2	$976K	Sell	220,926 -625,254	-74%	-$3.8M	0.01%	1197
2022 Q1	$7.7M	Buy	+846,180	New	+$9.74M	0.04%	494
2020 Q4	–	Sell	-539,897	Closed	-$5.33M	–	1505
2020 Q3	$5.33M	Buy	+539,897	New	+$3.11M	0.04%	429
2019 Q3	–	Sell	-12,873	Closed	-$78K	–	1185
2019 Q2	$78K	Sell	12,873 -5,603	-30%	-$39.3K	﹤0.01%	720
2019 Q1	$134K	Buy	+18,476	New	+$134K	﹤0.01%	905